Esophageal-reflux monitoring

Gastrointestinal Endoscopy

Volumn 69, Issue 4, 2009, Pages

  Pandolfino, John E ^a   Vela, Marcelo F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ACCURACY; ANTIREFLUX OPERATION; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL PATHWAY; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DIET; DIET RESTRICTION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG RESPONSE; DRUG WITHDRAWAL; ENDOSCOPY; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; GASTRIC PH MONITORING; GASTROESOPHAGEAL REFLUX; HUMAN; IMPEDANCE; INDWELLING CATHETER; LIFESTYLE MODIFICATION; PATIENT ASSESSMENT; PATIENT MONITORING; PH ELECTRODE; PH MEASUREMENT; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; STOMACH ACID; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 62949187223     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.09.022     Document Type: Review

References (92)

1. de Caestecker J.S., and Heading R.C. Esophageal pH monitoring. Gastroenterol Clin North Am 19 (1990) 645-669
2. McLauchlan G., Rawlings J.M., Lucas M.L., et al. Electrodes for 24 hours pH monitoring: a comparative study. Gut 28 (1987) 935-939
3. Geus W.P., Smout A.J., Kooiman J.C., et al. Glass and antimony electrodes for long-term pH monitoring: a dynamic in vitro comparison. Eur J Gastroenterol Hepatol 7 (1995) 29-35
4. Duroux P., Emde C., Bauerfeind P., et al. The ion sensitive field effect transistor (ISFET) pH electrode: a new sensor for long term ambulatory pH monitoring. Gut 32 (1991) 240-245
5. Kahrilas P.J., and Quigley E.M. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 110 (1996) 1982-1996
6. Pandolfino J.E., Ghosh S., Zhang Q., et al. Slimline vs. glass pH electrodes: what degree of accuracy should we expect?. Aliment Pharmacol Ther 23 (2006) 331-340
7. Pandolfino J.E., Schreiner M.A., Lee T.J., et al. Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol 100 (2005) 1466-1476
8. Pandolfino J.E., Zhang Q., Schreiner M.A., et al. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?. Gut 54 (2005) 1687-1692
9. des Varannes S.B., Mion F., Ducrotte P., et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 54 (2005) 1682-1686
10. Wong W.M., Bautista J., Dekel R., et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring: a randomized trial. Aliment Pharmacol Ther 21 (2005) 155-163
11. Pandolfino J.E., Richter J.E., Ours T., et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98 (2003) 740-749
12. Prakash C., Jonnalagadda S., Azar R., et al. Endoscopic removal of the wireless pH monitoring capsule in patients with severe discomfort. Gastrointest Endosc 64 (2006) 828-832
13. Bhat Y.M., McGrath K.M., and Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol 40 (2006) 116-121
14. Mattox III H.E., and Richter J.E. Prolonged ambulatory esophageal pH monitoring in the evaluation of gastroesophageal reflux disease. Am J Med 89 (1990) 345-356
15. Price J., and Richter J.E. The performance and interpretation of ambulatory esophageal pH monitoring in adults. In: Richter J.E. (Ed). Ambulatory esophageal pH monitoring: practical approach and clinical applications. 2nd ed. (1997), Williams and Wilkins, Baltimore 27-38
16. Klauser A.G., Schindlbeck N.E., and Muller-Lissner S.A. Esophageal 24-h pH monitoring: is prior manometry necessary for correct positioning of the electrode?. Am J Gastroenterol 85 (1990) 1463-1467
17. Walther B., and DeMeester T. Placement of the esophageal pH electrode for 24 hour esophageal pH monitoring. In: DeMeester T., and Skinner D.B. (Eds). Esophageal disorders: pathophysiology and therapy (1985), Raven, New York 539-541
18. Lacy B.E., O'Shana T., Hynes M., et al. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol 102 (2007) 24-32
19. Marchese M., Spada C., Iacopini F., et al. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure. Endoscopy 38 (2006) 813-818
20. Dekel R., Malagon I.B., Green C., et al. Comparison of transnasally placed wireless pH capsule (Bravo) versus traditional 24-hour esophageal pH monitoring. [abstract]. Am J Gastroenterol 98 (2003) A108
21. Weusten B.L., Akkermans L.M., vanBerge-Henegouwen G.P., et al. Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 266 (1994) G357-G362
22. McCollough M., Jabbar A., Cacchione R., et al. Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate. Dig Dis Sci 49 (2004) 1607-1611
23. Dobhan R., and Castell D.O. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 88 (1993) 25-29
24. Cool M., Poelmans J., Feenstra L., et al. Characteristics and clinical relevance of proximal esophageal pH monitoring. Am J Gastroenterol 99 (2004) 2317-2323
25. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 (1991) 1-78
26. Bove M., Ruth M., Cange L., et al. 24-H pharyngeal pH monitoring in healthy volunteers: a normative study. Scand J Gastroenterol 35 (2000) 234-241
27. Wiener G.J., Koufman J.A., Wu W.C., et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 84 (1989) 1503-1508
28. Williams R.B., Ali G.N., Wallace K.L., et al. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insights into mechanisms. Gastroenterology 117 (1999) 1051-1061
29. Katz P.O. Ambulatory intragastric pH monitoring: clinical laboratory to clinical practice. Rev Gastroenterol Disord 3 Suppl 4 (2003) S3-S9
30. Yamaguchi T., Seza A., Odaka T., et al. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance. Gastrointest Endosc 63 (2006) 1046-1050
31. Bell N.J., Burget D., Howden C.W., et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 50 Suppl 1 (1992) 59-67
32. Fackler W.K., Ours T.M., Vaezi M.F., et al. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122 (2002) 625-632
33. Dhiman R.K., Saraswat V.A., and Naik S.R. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci 47 (2002) 241-250
34. Dobhan R., and Castell D.O. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis. Dig Dis Sci 37 (1992) 857-864
35. Choiniere L., Miller L., Ilves R., et al. A simplified method of esophageal pH monitoring for assessment of gastroesophageal reflux. Ann Thorac Surg 36 (1983) 596-603
36. Grande L., Pujol A., Ros E., et al. Intraesophageal pH monitoring after breakfast + lunch in gastroesophageal reflux. J Clin Gastroenterol 10 (1988) 373-376
37. Fink S.M., and McCallum R.W. The role of prolonged esophageal pH monitoring in the diagnosis of gastroesophageal reflux. JAMA 252 (1984) 1160-1164
38. Galmiche J.P., Guillard J.F., Denis P., et al. A study of post-prandial oesophageal pH in healthy subjects and in patients with gastro-oesophageal reflux. Diagnostic value of a scoring index of acid reflux. [French]. Gastroenterol Clin Biol 4 (1980) 531-539
39. Arora A.S., and Murray J.A. Streamlining 24-hour pH study for GERD: use of a 3-hour postprandial test. Dig Dis Sci 48 (2003) 10-15
40. Johnsson F., and Joelsson B. Reproducibility of ambulatory oesophageal pH monitoring. Gut 29 (1988) 886-889
41. Dalby K., Nielsen R.G., Markoew S., et al. Reproducibility of 24-hour combined multiple intraluminal impedance (MII) and pH measurements in infants and children. Evaluation of a diagnostic procedure for gastroesophageal reflux disease. Dig Dis Sci 52 (2007) 2159-2165
42. Dhiman R.K., Saraswat V.A., Mishra A., et al. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 41 (1996) 764-772
43. Ahlawat S.K., Novak D.J., Williams D.C., et al. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system. J Clin Gastroenterol 40 (2006) 20-24
44. Ward E.M., Devault K.R., Bouras E.P., et al. Successful oesophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 19 (2004) 449-454
45. Hirano I. Dual receiver, Four-day Bravo pH probe combining testing off and on PPI. Clin Gastroenterol Hepatol 3 (2005) 1083-1088
46. Hirano I. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease-Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Aliment Pharmacol Ther 23 Suppl 1 (2006) 12-24
47. Scarpulla G., Camilleri S., Galante P., et al. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 102 (2007) 2642-2647
48. Prakash C., and Clouse R.E. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 3 (2005) 329-334
49. Hirano I., Zhang Q., Pandolfino J.E., et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 3 (2005) 1083-1088
50. Garrean C.P., Gonsalves N., and Hirano I. Bravo pH testing on and off treatment with immediate-release omeprazole. Gastroenterol Hepatol 3 (2007) 4-7
51. Agrawal A., Tutuian R., Hila A., et al. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci 50 (2005) 1916-1920
52. Hila A., Agrawal A., and Castell D.O. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 5 (2007) 172-177
53. Fass J., Silny J., Braun J., et al. Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients. Scand J Gastroenterol 29 (1994) 693-702
54. Sifrim D., Castell D., Dent J., et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53 (2004) 1024-1031
55. Bredenoord A.J., Weusten B.L., Timmer R., et al. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol 100 (2005) 265-269
56. Shay S., Tutuian R., Sifrim D., et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 99 (2004) 1037-1043
57. Zerbib F., des Varannes S.B., Roman S., et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 22 (2005) 1011-1021
58. Roman S., Bruley des Varannes S., Pouderoux P., et al. Ambulatory 24-h oesophageal impedance-pH recordings: reliability of automatic analysis for gastro-oesophageal reflux assessment. Neurogastroenterol Motil 18 (2006) 978-986
59. Johnson L.F., and DeMeester T.R. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 8 Suppl 1 (1986) 52-58
60. Johnson L.F., and Demeester T.R. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 62 (1974) 325-332
61. Wenner J., Johnsson F., Johansson J., et al. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 40 (2005) 768-774
62. Vitale G.C., Cheadle W.G., Sadek S., et al. Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg 200 (1984) 724-728
63. Mattioli S., Pilotti V., Spangaro M., et al. Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 34 (1989) 71-78
64. Baldi F., Ferrarini F., Longanesi A., et al. Ambulatory 24-hour oesophageal pH monitoring in normal subjects: a multicentre study in Italy. G.I.S.M.A.D. GOR Study Group. Ital J Gastroenterol 23 (1991) 477-480
65. Richter J.E., Bradley L.A., DeMeester T.R., et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 37 (1992) 849-856
66. Vaezi M.F., and Richter J.E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111 (1996) 1192-1199
67. Avidan B., Sonnenberg A., Schnell T.G., et al. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus. Dig Dis Sci 47 (2002) 256-264
68. Campos G.M., Peters J.H., DeMeester T.R., et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3 (1999) 292-300
69. Khajanchee Y.S., Hong D., Hansen P.D., et al. Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results. Am J Surg 187 (2004) 599-603
70. Vela M.F., Camacho-Lobato L., Srinivasan R., et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 120 (2001) 1599-1606
71. Sifrim D., Holloway R., Silny J., et al. Composition of the postprandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 96 (2001) 647-655
72. Zentilin P., Iiritano E., Dulbecco P., et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis 38 (2006) 226-232
73. Wiener G.J., Morgan T.M., Copper J.B., et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33 (1988) 1127-1133
74. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 107 (1994) 1741-1745
75. Singh S., Richter J.E., Bradley L.A., et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci 38 (1993) 1402-1408
76. Wenner J., Johnsson F., Johansson J., et al. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 102 (2007) 239-245
77. Croffie J.M., Fitzgerald J.F., Molleston J.P., et al. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years. J Pediatr Gastroenterol Nutr 45 (2007) 559-563
78. Pandolfino J., Zhang Q., Schreiner M., et al. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?. Gut 54 (2005) 16878-16892
79. Mainie I., Tutuian R., Shay S., et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 55 (2006) 1398-1402
80. Bredenoord A.J., Weusten B.L., Timmer R., et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 101 (2006) 453-459
81. DeVault K.R., and Castell D.O. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 100 (2005) 190-200
82. Bredenoord A.J., Weusten B.L., Curvers W.L., et al. Determinants of perception of heartburn and regurgitation. Gut 55 (2006) 313-318
83. Hirano I., and Richter J.E. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 102 (2007) 668-685
84. Charbel S., Khandwala F., and Vaezi M.F. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol 100 (2005) 283-289
85. Milkes D., Gerson L.B., and Triadafilopoulos G. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal and intragastric pH in patients with gastroesophageal reflux disease (GERD). Am J Gastroenterol 99 (2004) 991-996
86. Katzka D.A., Paoletti V., Leite L., et al. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol 91 (1996) 2110-2113
87. Aanen M.C., Weusten B.L., Numans M.E., et al. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. J Clin Gastroenterol 42 (2008) 441-447
88. Taghavi S.A., Ghasedi M., Saberi-Firoozi M., et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut 54 (2005) 1067-1071
89. Connor J., and Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol 101 (2006) 460-463
90. Carlsson R., Galmiche J.P., Dent J., et al. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials. Aliment Pharmacol Ther 11 (1997) 473-482
91. Fass R., Murthy U., Hayden C.W., et al. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy: a prospective, randomized, multi-centre study. Aliment Pharmacol Ther 14 (2000) 1595-1603
92. Jackson P.G., Gleiber M.A., Askari R., et al. Predictors of outcome in 100 consecutive laparoscopic antireflux procedures. Am J Surg 181 (2001) 231-235